PromarkerD international validation study results published

Medical Technology company Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to announce the publication of the successful validation results from a major multi-centre clinical study confirming the effectiveness of PromarkerD as a predictive test for diabetic kidney disease.

Media Release


  • This field is for validation purposes and should be left unchanged.